hydrochlorothiazide has been researched along with doxazosin in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (18.52) | 18.7374 |
| 1990's | 10 (37.04) | 18.2507 |
| 2000's | 7 (25.93) | 29.6817 |
| 2010's | 3 (11.11) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Agabiti-Rosei, E; Beschi, M; Calebich, S; Castellano, M; Muiesan, G; Muiesan, ML; Rizzoni, D; Zulli, R | 1 |
| Nelson, EB; Pool, JL; Taylor, AA | 1 |
| Pool, JL | 1 |
| Claessens, J; Nelemans, F; Riesen, W; Streulens, Y; Trost, BN; Weidmann, P | 1 |
| Cox, DA; Leader, JP; Milson, JA; Singleton, W | 1 |
| Daae, L; Hjermann, I; Hjortdahl, P; Holme, I; von Krogh, H | 1 |
| Jones, DW; Sands, CD | 1 |
| Agbedana, EO; Ahaneku, JE; Salako, LA; Taylor, GO; Walker, O | 1 |
| Carruthers, G; Dessain, P; Fodor, G; Newman, C; Palmer, W; Sim, D | 1 |
| Agbedana, OE; Ahaneku, JE; Taylor, OG | 1 |
| Flack, JM; Gonzalez, NM; Grimm, RH; Liebson, PR; Schoenberger, JA | 1 |
| Ahaneku, JE | 1 |
| Agbedana, EO; Ahaneku, JE; Salako, LA; Sowunmi, A; Taylor, GO; Walker, O | 1 |
| Half-Onn, E; Levi, Z; Rachmani, R; Ravid, M; Slavachevsky, I | 1 |
| Ritz, E; Schwenger, V; Zeier, M | 1 |
| Fukuzawa, M; Miyaguchi, S; Nakazawa, T; Ohta, S; Qiang, X; Sakata, Y; Satoh, J; Takahashi, K; Takizawa, Y; Toyota, T | 1 |
| Birkenhägeri, JC; de Groot, E; de Heide, LH; de Ridder, MA; Hoogerbrugge, N; Jansen, H; Stijnen, T | 1 |
| Alcázar, JM; Campo, C; Rodicio, JL; Roldán, C; Ruilope, LM; Segura, J | 1 |
| Dobrokhod, AS; Kushnir, SM; Radchenko, GD; Sirenko, YM; Torbas, OO | 1 |
| Brown, MJ; Caulfield, M; Cruickshank, JK; Ford, I; MacDonald, TM; Mackenzie, IS; McCann, GP; McInnes, G; Morant, S; Padmanabhan, S; Salsbury, J; Sever, P; Webb, DJ; Williams, B | 1 |
| Böhm, M; Götzinger, F; Hohl, M; Hübner, U; Lauder, L; Lehnert, U; Mahfoud, F; Meyer, MR; Schneider, C; Sevimli, Ö; Tokcan, M; Wagmann, L | 1 |
2 review(s) available for hydrochlorothiazide and doxazosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Doxazosin; Humans; Hydrochlorothiazide; Hypertension; Lipoproteins; Prazosin | 1989 |
16 trial(s) available for hydrochlorothiazide and doxazosin
| Article | Year |
|---|---|
Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Doxazosin; Humans; Hydrochlorothiazide; Hypertension; Lipids; Placebos; Prazosin | 1987 |
Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Prazosin; Prospective Studies; Random Allocation | 1987 |
The antihypertensive effects of doxazosin: a clinical overview.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Kinetics; Male; Metoprolol; Middle Aged; Nadolol; Prazosin; Propanolamines; Random Allocation; Risk; Triglycerides | 1986 |
A 24-week multicenter double-blind study of doxazosin and hydrochlorothiazide in patients with mild to moderate essential hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Prazosin; Random Allocation; Time Factors | 1987 |
Effects of doxazosin and hydrochlorothiazide on lipid levels in Korean patients with essential hypertension.
Topics: Adult; Aged; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Diet; Double-Blind Method; Doxazosin; Female; Humans; Hydrochlorothiazide; Hypertension; Korea; Lipids; Male; Middle Aged; Triglycerides | 1993 |
Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Topics: Adult; Aged; Amiloride; Amlodipine; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Doxazosin; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Lipids; Lipoproteins; Middle Aged | 1994 |
Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group.
Topics: Adult; Aged; Atenolol; Cholesterol; Cholesterol, HDL; Coronary Disease; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Risk Factors | 1993 |
Relationship between body mass index (BMI) and changes in plasma total and HDL-cholesterol levels during treatment of hypertension in African patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Black People; Body Mass Index; Cholesterol; Cholesterol, HDL; Doxazosin; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nigeria | 1995 |
Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide.
Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Diuretics; Double-Blind Method; Doxazosin; Echocardiography; Female; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Patient Compliance; Pulse; Quality of Life; Sodium Chloride Symporter Inhibitors | 1996 |
Blood pressure and blood glucose levels during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Topics: Adult; Aged; Amiloride; Amlodipine; Antihypertensive Agents; Blood Glucose; Blood Pressure; Cross-Over Studies; Doxazosin; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Treatment Outcome | 1996 |
Biochemical changes during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Topics: Adult; Aged; Amiloride; Amlodipine; Antihypertensive Agents; Blood Proteins; Calcium; Creatinine; Cross-Over Studies; Double-Blind Method; Doxazosin; Drug Combinations; Electrolytes; Humans; Hydrochlorothiazide; Hypertension; Middle Aged | 1996 |
Effect of an alpha-adrenergic blocker, and ACE inhibitor and hydrochlorothiazide on blood pressure and on renal function in type 2 diabetic patients with hypertension and albuminuria. A randomized cross-over study.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cilazapril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Doxazosin; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney Function Tests; Male; Middle Aged | 1998 |
Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands.
Topics: Aged; Antihypertensive Agents; Arteriosclerosis; Carotid Arteries; Disease Progression; Diuretics; Double-Blind Method; Doxazosin; Femoral Artery; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors | 2002 |
Doxazosin GITS versus hydrochlorothiazide as add-on therapy in patients with uncontrolled hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cholesterol; Doxazosin; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Treatment Outcome; Uric Acid | 2003 |
Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Chi-Square Distribution; Diuretics; Doxazosin; Drug Combinations; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Pulse Wave Analysis; Severity of Illness Index; Time Factors; Treatment Outcome; Ukraine; Vascular Stiffness | 2013 |
Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Treatment Outcome; Young Adult | 2017 |
9 other study(ies) available for hydrochlorothiazide and doxazosin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.
Topics: Adrenergic alpha-Antagonists; Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Catecholamines; Diastole; Dose-Response Relationship, Drug; Doxazosin; Drug Therapy, Combination; Female; Heart Rate; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Organ Size; Prazosin; Renin; Rest; Stress, Physiological; Systole; Time Factors | 1992 |
Antihypertensive therapy in renal patients - benefits and difficulties.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Diuretics; Doxazosin; Humans; Hydrochlorothiazide; Hypertension, Renal; Kidney Failure, Chronic; Kidney Glomerulus; Male; Nitrendipine; Proteinuria; Renal Circulation; Triamterene | 1999 |
Modulation of tumor necrosis factor-alpha production with anti-hypertensive drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amlodipine; Animals; Antihypertensive Agents; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Diuretics; Doxazosin; Humans; Hydrochlorothiazide; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Metoprolol; Mice; Mice, Inbred BALB C; Monocytes; Nicardipine; Nitrobenzenes; Piperazines; Sodium Chloride Symporter Inhibitors; Tumor Necrosis Factor-alpha | 2000 |
Efficacy of Antihypertensive Drugs of Different Classes After Renal Denervation in Spontaneously Hypertensive Rats.
Topics: Aldosterone; Amlodipine; Animals; Antihypertensive Agents; Bisoprolol; Blood Pressure; Cardiomyopathies; Denervation; Doxazosin; Hydrochlorothiazide; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Renin; Sympathectomy | 2023 |